ASHLEY CENA: Open Payments
NPI 1821875915 · RISING SUN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 13 payments from 9 companies in 2025. Trend: 2023 $63 · 2024 $217 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
Products named: PREVNAR 20, ROTATEQ, ZORYVE, AIRSUPRA, FANAPT, KISUNLA, QULIPTA, Fluad.
Industry payments across MD — which companies pay providers there.
